Susan Sabo-Wagner, MSN, RN, OCN, of the American Oncology Network, expressed excitement toward networking, innovative discussions, and panels on patient advocacy at Patient-Centered Oncology Care® (PCOC) 2024.
Patient-Centered Oncology Care® (PCOC) 2024 will take place in Nashville, Tennessee, from September 12 to 13. The meeting will showcase experts in the oncology space with discussions surrounding recent innovations that target patient care to increase quality of life.
Susan Sabo-Wagner, MSN, RN, OCN, vice president of clinical innovation at the American Oncology Network, serves as cochair for PCOC this year. In this interview, she explains why she is looking forward to networking and the panels on patient advocacy.
This transcript has been lightly edited for clarity.
Transcript
What are you looking forward to most as cochair of PCOC this year?
The things that I'm most looking forward to is, number one, networking. I think PCOC really brings [together] quite a large group of very interesting people across the oncology spectrum. I love to get together to see everybody that comes to that. I think there's a lot of very interesting speakers this year, from the keynote to all of the different panels.
I was actually just taking a look at the agenda this morning, and I'm very interested in some of the innovation discussions and a lot of the specific discussions on that. Then I saw that there's a couple of prizes, so I think that's a really cool addition this year.
What panels or specific topics are you looking forward to being discussed at PCOC?
I think anything around patient-specific advocacy. There's a couple of different panels dedicated to the different aggregating organizations, and I think that's going to be very interesting to understand. And I think just kind of getting to know what everybody's doing in this space. There's been a lot of changes and reimbursement changes this year, so understanding how everyone is impacted and how they're making changes to face those.
Stuck in Prior Auth Purgatory: The Hidden Costs of Health Care Delays
June 19th 2025Delays, denials, and endless paperwork—prior authorization isn’t just a headache for providers; it’s a barrier for patients who need timely care, explains Colin Banas, MD, MHA, chief medical officer with DrFirst.
Listen
Targeting the Root of gMG With Inebilizumab: A Q&A With Richard Nowak, MD, MS
June 24th 2025In this interview, Richard J. Nowak, MD, MS, principal investigator of the MINT trial of inebilizumab for generalized myasthenia gravis (gMG), discusses the trial’s key findings, including significant improvements in patient- and physician-assessed outcomes, as well as longer-term implications and future areas of investigation.
Read More